Clearside Biomedical (STU:CLM) FCF Yield % : -20.34 (As of May. 05, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Clearside Biomedical FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Clearside Biomedical's Trailing 12-Month Free Cash Flow is €-18.55 Mil, and Market Cap is €91.23 Mil. Therefore, Clearside Biomedical's FCF Yield % for today is -20.34%.

The historical rank and industry rank for Clearside Biomedical's FCF Yield % or its related term are showing as below:

STU:CLM' s FCF Yield % Range Over the Past 10 Years
Min: -290.59 Med: -18.47 Max: 0.3
Current: -20.34

During the past 11 years, the highest FCF Yield % of Clearside Biomedical was 0.30%. The lowest was -290.59%. And the median was -18.47%.

STU:CLM's FCF Yield % is ranked worse than
58.66% of 1553 companies
in the Biotechnology industry
Industry Median: -14.39 vs STU:CLM: -20.34

Clearside Biomedical's FCF Margin % for the quarter that ended in Dec. 2023 was 5.91%.

Clearside Biomedical FCF Yield % Historical Data

The historical data trend for Clearside Biomedical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearside Biomedical FCF Yield % Chart

Clearside Biomedical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-20.96

-12.59

-6.63

-21.07

-27.67

Clearside Biomedical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-34.72	-47.85	-35.99	-50.12	2.09

Competitive Comparison of Clearside Biomedical's FCF Yield %

For the Biotechnology subindustry, Clearside Biomedical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearside Biomedical's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearside Biomedical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Clearside Biomedical's FCF Yield % falls into.

Clearside Biomedical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Clearside Biomedical's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-18.26	/	65.99334
	=	-27.67%

Clearside Biomedical's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0.344	*	4	/	65.99334
	=	2.09%

Clearside Biomedical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Clearside Biomedical FCF Yield % Related Terms

Thank you for viewing the detailed overview of Clearside Biomedical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearside Biomedical (STU:CLM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (STU:CLM) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

CLSD:USA CLM:Germany

Address

900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005

Website

https://www.clearsidebio.com

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.